Chad F. Phipps, Senior Vice President, Chief Legal and Corporate Affairs Officer and Secretary of Zimmer Biomet Holdings, Inc., filed a Form 4 on September 9, 2026, disclosing a sale of common stock that occurred on September 4, 2026.
Andrew Spodek, CEO and Director of Postal Realty Trust, Inc., filed a Form 4 on September 9, 2026, disclosing the acquisition of OP Units on September 4, 2026, through two affiliated entities in connection with property contributions to subsidiaries of the issuer.
Mads Bodenhoff, Senior Vice President and Principal Accounting Officer of Ascendis Pharma A/S (NASDAQ:ASND), filed a Form 4 on September 10, 2026, reporting transactions in ordinary shares and warrants dated September 8, 2026.
A Form 4 filed on September 9, 2026, discloses that Andy Dignan, President of Five9, Inc. (NASDAQ:FIVN), sold a total of 13,320 shares of common stock across four transactions between September 4 and September 8, 2026.
Tiffany N. Meriweather, Chief Administrative and Legal Officer of Five9, Inc., filed a Form 4 on September 9, 2026, disclosing the sale of a combined 18,523 shares of common stock across three transactions between September 4 and September 8, 2026.
Bryan M. Lee, Chief Financial Officer of Five9, Inc. (NASDAQ:FIVN), filed a Form 4 on September 9, 2026, disclosing four sales of common stock executed on September 4 and September 8, 2026.
Alexandre Clerc, Senior Vice President of Customers at Frontier Group Holdings, Inc., filed a statement of changes in beneficial ownership on September 9, 2026, disclosing a sale of common stock that occurred on September 4, 2026.
Steve Schuller, Senior Vice President of Human Resources at Frontier Group Holdings, Inc., filed a Form 4 on September 9, 2026, disclosing the sale of 7,500 shares of common stock on September 4, 2026.
Jason Drew Smith, General Counsel of UroGen Pharma Ltd. (NASDAQ:URGN), filed a Form 4 on September 9, 2026, disclosing the vesting of restricted stock units and a subsequent sale of ordinary shares on September 7 and 8, 2026.
JFrog Ltd Chief Technology Officer Yoav Landman filed a Form 4 with the SEC on September 9, 2026, disclosing the sale of ordinary shares on September 4, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.